Corpus Intelligence IC Memo — FLINT RIVER COMMUNITY HOSPITAL 2026-04-26 04:04 UTC
IC Memo — FLINT RIVER COMMUNITY HOSPITAL
Investment Committee Memorandum | GA | 22 beds | Grade D | EBITDA uplift $622K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FLINT RIVER COMMUNITY HOSPITAL

CCN 110190 | MACON, GA | 22 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

FLINT RIVER COMMUNITY HOSPITAL is a 22-bed safety-net/medicaid heavy in MACON, GA with $8.3M in net patient revenue and a -10.5% operating margin. The hospital serves a payer mix of 4.3% Medicare, 39.4% Medicaid, and 56.4% commercial.

Thesis: Turnaround. Our ML models identify $622K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -10.5% to -3.0% (+746bps).

Net Revenue HCRIS$8.3M
Current EBITDA COMPUTED$-872K
Operating Margin COMPUTED-10.5%
Occupancy HCRIS1.2%
Revenue / Bed COMPUTED$379K
Net-to-Gross HCRIS51.4%
Distress Probability ML69.5%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
53
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of -10.5% places it below the state median. Among 53 size-comparable peers (11-44 beds), the median margin is -3.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (11-44), prioritizing same-state peers. 53 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FLINT RIVER COMMUNITY HOSPITAL (Target)GA22$8.3M-10.5%
UNION GENERAL HOSPITALGA39$108.6M2.4%
TATTNALL HOSPITAL COMPANY LLCGA25$101.7M41.9%
MILLER COUNTY HOSPITALGA25$81.6M-1.1%
BURKE MEDICAL CENTERGA40$55.7M34.7%
SGHS - CAMDEN CAMPUSGA40$54.9M-10.3%
EFFINGHAM HOSPITALGA25$53.8M-39.8%
STEPHENS COUNTY HOSPITALGA40$49.4M6.0%
LIBERTY REGIONAL MEDICAL CENTEGA25$46.0M-14.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $622K (746bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$175K+210bp18mo
Denial Rate Reduction12.0%6.5%$169K+202bp12mo
Cost to Collect4.5%2.5%$167K+200bp12mo
A/R Days Reduction5200.0%3800.0%$102K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+12bp6mo

5. EBITDA Bridge

Net Collection Rate
$175K
Denial Rate Reduction
$169K
Cost to Collect
$167K
A/R Days Reduction
$102K
Clean Claim Rate
$10K
Total EBITDA Uplift$622K
Current EBITDA$-872K
+ RCM Uplift+$622K
Pro Forma EBITDA$-250K
Current Margin-10.5%
Pro Forma Margin-3.0%
WC Released (1x)$320K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.3M$467K0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.3M$78K0.00x-100.0%
Bull Case9.0x11.0x$-1.2M$1.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.2M$1.5M0.00x-100.0%
Bear Case11.0x10.0x$-1.5M$-2.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.5M$-2.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (39.4%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
MediumLow occupancyAt 1.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 69.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 53 hospitals with 11-44 beds
  • Same-state prioritization (n=54)
  • Comp margins: P25=-18.3% / P50=-3.7% / P75=5.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.